Works matching IS 22107703 AND DT 2025 AND VI 47 AND IP 2
Results: 28
52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice: 21–23 October 2024, Kraków, Poland: 52nd ESCP Symposium on Clinical Pharmacy Implementing and scaling sustainable clinical pharmacy practice
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 484, doi. 10.1007/s11096-025-01891-6
- Publication type:
- Article
Correction: Preadmission medications and recent falls in older inpatients: an observational study.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Correction: Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Comment on: "whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis".
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 584, doi. 10.1007/s11096-025-01877-4
- By:
- Publication type:
- Article
Community pharmacists improving equitable access to contraceptive methods: a commentary.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 477, doi. 10.1007/s11096-025-01870-x
- By:
- Publication type:
- Article
Principles and Practice of Pharmacovigilance and Drug Safety: J. Jimmy, A.R. Cox, V. Paudyal (eds).
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 586, doi. 10.1007/s11096-024-01862-3
- By:
- Publication type:
- Article
Efficacy and safety of preoperative duloxetine in reducing post-laparoscopic surgery pain: a meta-analysis of randomized placebo-controlled trials.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 294, doi. 10.1007/s11096-024-01855-2
- By:
- Publication type:
- Article
Prophylaxis of topical levofloxacin against endophthalmitis after cataract surgery in Taiwan, 2001–2019: an interrupted time series analysis.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 462, doi. 10.1007/s11096-024-01853-4
- By:
- Publication type:
- Article
Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid® prescribing: a descriptive analysis.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 471, doi. 10.1007/s11096-024-01852-5
- By:
- Publication type:
- Article
Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 452, doi. 10.1007/s11096-024-01850-7
- By:
- Publication type:
- Article
Opioid prescribing prevalence and initiation rates in Victoria, Australia: insights from primary care data during a period of opioid policy changes (2017–2022).
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 443, doi. 10.1007/s11096-024-01849-0
- By:
- Publication type:
- Article
Awareness and use of tools to identify potentially inappropriate prescribing among physicians and pharmacists in Saudi Arabia: a nationwide cross-sectional study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 435, doi. 10.1007/s11096-024-01848-1
- By:
- Publication type:
- Article
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 423, doi. 10.1007/s11096-024-01847-2
- By:
- Publication type:
- Article
Established and emerging roles for pharmacy in operating theatres: a scoping review.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 270, doi. 10.1007/s11096-024-01845-4
- By:
- Publication type:
- Article
Barriers and facilitators to implementing polypharmacy management frameworks: a theory based qualitative exploration of key stakeholders.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 412, doi. 10.1007/s11096-024-01844-5
- By:
- Publication type:
- Article
Characteristics of hospital pharmacist interventions and their clinical, economic and organizational impacts: a five-year observational study on the French National Observatory.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 403, doi. 10.1007/s11096-024-01843-6
- By:
- Publication type:
- Article
Pharmacists' perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 392, doi. 10.1007/s11096-024-01842-7
- By:
- Publication type:
- Article
Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 382, doi. 10.1007/s11096-024-01841-8
- By:
- Publication type:
- Article
Medication reconciliation and seamless care led by clinical pharmacists in Slovenia: a national reimbursed program ensuring safe and effective transition of care.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 239, doi. 10.1007/s11096-024-01840-9
- By:
- Publication type:
- Article
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 373, doi. 10.1007/s11096-024-01838-3
- By:
- Publication type:
- Article
Translation, adaptation and psychometric testing of the Digital Health Technology Literacy Assessment Questionnaire (DHTL-AQ) in the Serbian language.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 365, doi. 10.1007/s11096-024-01837-4
- By:
- Publication type:
- Article
Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 247, doi. 10.1007/s11096-024-01834-7
- By:
- Publication type:
- Article
Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 354, doi. 10.1007/s11096-024-01832-9
- By:
- Publication type:
- Article
Community pharmacists' knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 345, doi. 10.1007/s11096-024-01831-w
- By:
- Publication type:
- Article
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 335, doi. 10.1007/s11096-024-01830-x
- By:
- Publication type:
- Article
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 325, doi. 10.1007/s11096-024-01829-4
- By:
- Publication type:
- Article
Evaluating the appropriateness and the factors associated with sodium-glucose co-transporter 2 inhibitors prescribing in a Middle Eastern country: a cross-sectional study.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 314, doi. 10.1007/s11096-024-01828-5
- By:
- Publication type:
- Article
Cost-effectiveness analysis of first line pembrolizumab monotherapy for high programmed cell death ligand 1 expressed, advanced non-small cell lung cancer in Japan.
- Published in:
- International Journal of Clinical Pharmacy, 2025, v. 47, n. 2, p. 304, doi. 10.1007/s11096-024-01826-7
- By:
- Publication type:
- Article